Vaccine advance-purchase agreements for low-income countries: Practical issues

被引：30

作者：

Berndt, ER ^{[1
]}

Hurvitz, JA

机构：

[1] MIT, Sloan Sch Management, Cambridge, MA USA

[2] NBER, Cambridge, MA 02138 USA

来源：

HEALTH AFFAIRS | 2005年 / 24卷 / 03期

关键词：

D O I：

10.1377/hlthaff.24.3.653

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

There are strong theoretical arguments for the creation of advance-purchase agreements to increase incentives for the development and production of vaccines for diseases concentrated in low-income countries. A Center for Global Development working group recently concluded that such agreements could be implemented successfully. We consider the practical economic and legal arrangements for such advance-purchase commitments. We identify several practical issues that we believe the public health and policy community should consider further in the design of an advance-purchase commitment.

引用

页码：653 / 665

页数：13

共 16 条

[1] Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial [J].

Alonso, PL ;

Sacarlal, J ;

Aponte, JJ ;

Leach, A ;

Macete, E ;

Milman, J ;

Mandomando, I ;

Spiessens, B ;

Guinovart, C ;

Espasa, M ;

Bassat, Q ;

Aide, P ;

Ofori-Anyinam, O ;

Navia, MM ;

Corachan, S ;

Ceuppens, M ;

Dubois, MC ;

Demoitié, MA ;

Dubovsky, F ;

Menéndez, C ;

Tornieporth, N ;

Ballou, WR ;

Thompson, R ;

Cohen, J .

LANCET, 2004, 364 (9443) :1411-1420

[2]

[Anonymous], 2020, 2020 DEV 3 WGI PROT

[3]

[Anonymous], 2004, MILLIONS SAVED PROVE

[4]

BERNDT ER, 2005, ANN M AM EC ASS PHIL

[5]

BROWN RTH, 2004, COMMUNICATION 1124

[6]

*GLOB ALL VACC IMM, 2005, ANN DEATHS 2002 VACC

[7]

*INT FED PHARM MAN, 2004, RES DEV NEGL DIS

[8]

Kalamas J, 2002, MCKINSEY Q, P9

[9]

KREMER M, 2001, INNOVATION POLICY EC

[10]

Kremer Michael, 2004, Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases

← 1 2 →